These observations possibly reflect molecular changes that occur during breast carcinogenesis in different histological types of breast cancer and indicate that RAD50 and LGALS3BP antigens are promising candidates for more comprehensive research as potential molecular markers for breast cancer diagnostics and therapy. Here, LGALS3BP is linked to breast carcinoma.